Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

Why did Wells Fargo's asset cap get lifted? How will Trump's tariff hikes impact the US economy? What caused Nvidia to regain top market value? Why are shareholders rejecting Warner Bros CEO pay? How is Meta addressing AI's energy demands? What impact will McDonald's Snack Wrap return have? Why is Dollar General seeing record sales amid tariffs?

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

ft.com/content/6acff1e0-e23e-4a46-a232-9da44ef2d5dd

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
Discover all the plans currently available in your country

This story appeared on ft.com, 2025-06-02 12:24:53.687000.